{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:57:09Z","timestamp":1774364229349,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02084-y","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:24:32Z","timestamp":1774355072000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Preparation and evaluation of citalopram novasomal vesicles as a transdermal analgesic drug delivery"],"prefix":"10.1007","author":[{"given":"Fereshte","family":"Haftan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katayoun","family":"Morteza-Semnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jafar","family":"Akbari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Seyedabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majid","family":"Saeedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2084_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejphar.2018.03.042","volume":"829","author":"A Barakat","year":"2018","unstructured":"Barakat A, Hamdy MM, Elbadr MM. Uses of fluoxetine in nociceptive pain management: a literature overview. Eur J Pharmacol. 2018;829:12\u201325.","journal-title":"Eur J Pharmacol"},{"issue":"10180","key":"2084_CR2","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/S0140-6736(19)30352-6","volume":"393","author":"P Glare","year":"2019","unstructured":"Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019;393(10180):1537\u201346.","journal-title":"Lancet"},{"issue":"2","key":"2084_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s12630-013-0087-4","volume":"61","author":"KA Mifflin","year":"2014","unstructured":"Mifflin KA, Kerr BJ. The transition from acute to chronic pain: understanding how different biological systems interact. Can J Anesth\/J Can Anesth. 2014;61(2):112\u201322.","journal-title":"Can J Anesth\/J Can Anesth"},{"key":"2084_CR4","doi-asserted-by":"publisher","first-page":"1596367","DOI":"10.3389\/fnmol.2025.1596367","volume":"18","author":"S Zhang","year":"2025","unstructured":"Zhang S, et al. Decoding pain chronification: mechanisms of the acute-to-chronic transition. Front Mol Neurosci. 2025;18:1596367.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"2084_CR5","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s42234-019-0023-1","volume":"5","author":"J Caylor","year":"2019","unstructured":"Caylor J, et al. Spinal cord stimulation in chronic pain: evidence and theory for mechanisms of action. Bioelectron Med. 2019;5(1):12.","journal-title":"Bioelectron Med"},{"issue":"6","key":"2084_CR6","doi-asserted-by":"publisher","first-page":"e00464","DOI":"10.1016\/j.neurot.2024.e00464","volume":"21","author":"Q Song","year":"2024","unstructured":"Song Q, et al. Neuroplasticity in the transition from acute to chronic pain. Neurotherapeutics. 2024;21(6):e00464.","journal-title":"Neurotherapeutics"},{"issue":"4","key":"2084_CR7","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1177\/2168479018794159","volume":"53","author":"MA Rane","year":"2019","unstructured":"Rane MA, et al. Benefits and risks of nonsteroidal anti-inflammatory drugs: methodologic limitations lead to clinical uncertainties. Ther Innov Regul Sci. 2019;53(4):502\u20135.","journal-title":"Ther Innov Regul Sci"},{"key":"2084_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106162","author":"A Nasir","year":"2025","unstructured":"Nasir A, et al. The persistent pain enigma: molecular drivers behind acute-to-chronic transition. Neurosci Biobehav Rev. 2025. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106162.","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"2084_CR9","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1124\/jpet.122.001278","volume":"382","author":"JG Yost","year":"2022","unstructured":"Yost JG, et al. Antinociceptive and analgesic effects of (2 R, 6 R)-hydroxynorketamine. J Pharmacol Exp Ther. 2022;382(3):256\u201365.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2084_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.neuropharm.2004.09.012","volume":"48","author":"SF Bomholt","year":"2005","unstructured":"Bomholt SF, Mikkelsen JD, Blackburn-Munro G. Antinociceptive effects of the antidepressants amitriptyline, duloxetine, mirtazapine and citalopram in animal models of acute, persistent and neuropathic pain. Neuropharmacology. 2005;48(2):252\u201363.","journal-title":"Neuropharmacology"},{"issue":"6","key":"2084_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.euroneuro.2005.11.013","volume":"16","author":"S Schreiber","year":"2006","unstructured":"Schreiber S, Pick CG. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. Eur Neuropsychopharmacol. 2006;16(6):464\u20138.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"2084_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejpain.2004.03.003","volume":"9","author":"M Aragona","year":"2005","unstructured":"Aragona M, et al. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder. Eur J Pain. 2005;9(1):33\u20138.","journal-title":"Eur J Pain"},{"issue":"1","key":"2084_CR13","first-page":"2020915","volume":"2016","author":"E Patetsos","year":"2016","unstructured":"Patetsos E, Horjales-Araujo E. Treating chronic pain with SSRIs: what do we know? Pain Res Manag. 2016;2016(1):2020915.","journal-title":"Pain Res Manag"},{"key":"2084_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00004850-199603001-00007","volume":"11","author":"C Muldoon","year":"1996","unstructured":"Muldoon C. The safety and tolerability of citalopram. Int Clin Psychopharmacol. 1996;11:35\u201340.","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"2084_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ph12020099","volume":"12","author":"DA Belinskaia","year":"2019","unstructured":"Belinskaia DA, et al. Psychotropic drugs for the management of chronic pain and itch. Pharmaceuticals. 2019;12(2): 99.","journal-title":"Pharmaceuticals"},{"issue":"6","key":"2084_CR16","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/S1734-1140(13)71522-6","volume":"65","author":"J Mika","year":"2013","unstructured":"Mika J, et al. Neuronal and immunological basis of action of antidepressants in chronic pain\u2013clinical and experimental studies. Pharmacol Rep. 2013;65(6):1611\u201321.","journal-title":"Pharmacol Rep"},{"key":"2084_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cis.2013.11.018","volume":"205","author":"C Marianecci","year":"2014","unstructured":"Marianecci C, et al. Niosomes from 80s to present: the state of the art. Adv Colloid Interface Sci. 2014;205:187\u2013206.","journal-title":"Adv Colloid Interface Sci"},{"key":"2084_CR18","doi-asserted-by":"crossref","unstructured":"Patel DK, Kesharwani R, Kumar V. Lipid nanoparticle topical and transdermal delivery: a review on production, penetration mechanism to skin. Int J Pharm Investig. 2019;9(4).","DOI":"10.5530\/ijpi.2019.4.28"},{"key":"2084_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2014.04.015","volume":"185","author":"S Moghassemi","year":"2014","unstructured":"Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22\u201336.","journal-title":"J Control Release"},{"issue":"1-2","key":"2084_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0378-5173(98)00169-0","volume":"172","author":"IF Uchegbu","year":"1998","unstructured":"Uchegbu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172(1\u20132):33\u201370.","journal-title":"Int J Pharm"},{"key":"2084_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2147\/IJN.S287383","volume":"16","author":"S Mosallam","year":"2021","unstructured":"Mosallam S, et al. Use of novasomes as a vesicular carrier for improving the topical delivery of terconazole: in vitro characterization, in vivo assessment and exploratory clinical experimentation. Int J Nanomed. 2021;16:119\u201332.","journal-title":"Int J Nanomed"},{"issue":"1","key":"2084_CR22","first-page":"26","volume":"2","author":"A illastria Rosalina","year":"2023","unstructured":"illastria Rosalina A, Sagita E, Iskandarsyah I. Novasome: combining ufasome and niosome for excellent vesicular drug delivery system. Sci Pharm. 2023;2(1):26\u201336.","journal-title":"Sci Pharm"},{"key":"2084_CR23","doi-asserted-by":"publisher","first-page":"105912","DOI":"10.1016\/j.jddst.2024.105912","volume":"98","author":"MA Abdelbari","year":"2024","unstructured":"Abdelbari MA, et al. Investigating the potential of novasomes in improving the trans-tympanic delivery of niflumic acid for effective treatment of acute otitis media. J Drug Deliv Sci Technol. 2024;98:105912.","journal-title":"J Drug Deliv Sci Technol"},{"key":"2084_CR24","doi-asserted-by":"crossref","unstructured":"Barry BW. Mode of action of penetration enhancers in human skin. J Control Release. 1987;6(1):85\u201397.","DOI":"10.1016\/0168-3659(87)90066-6"},{"issue":"6","key":"2084_CR25","doi-asserted-by":"publisher","first-page":"857","DOI":"10.2174\/1567201812666150901111930","volume":"13","author":"R B Patel","year":"2016","unstructured":"B Patel R, Thakore SD, Patel MR. Recent survey on patents of nanoemulsions. Curr Drug Deliv. 2016;13(6):857\u201381.","journal-title":"Curr Drug Deliv"},{"issue":"9","key":"2084_CR26","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3390\/molecules27092936","volume":"27","author":"I Fatima","year":"2022","unstructured":"Fatima I, et al. Novasomes as nano-vesicular carriers to enhance topical delivery of fluconazole: a new approach to treat fungal infections. Molecules. 2022;27(9):2936.","journal-title":"Molecules"},{"key":"2084_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","volume":"107","author":"E Nb","year":"1953","unstructured":"Nb E. Synthetic analgesics. II-dithienylbutenyl and dithienylbutylamines. J Pharmacol Exp Ther. 1953;107:385\u201393.","journal-title":"J Pharmacol Exp Ther"},{"key":"2084_CR28","doi-asserted-by":"crossref","unstructured":"Bannon AW, Malmberg AB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. 2007","DOI":"10.1002\/0471142301.ns0809s41"},{"issue":"12","key":"2084_CR29","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/0028-3908(89)90011-7","volume":"28","author":"O Fasmer","year":"1989","unstructured":"Fasmer O, Hunskaar S, Hole K. Antinociceptive effects of serotonergic reuptake inhibitors in mice. Neuropharmacology. 1989;28(12):1363\u20136.","journal-title":"Neuropharmacology"},{"issue":"19","key":"2084_CR30","doi-asserted-by":"publisher","first-page":"11737","DOI":"10.3390\/ijms231911737","volume":"23","author":"I Boarescu","year":"2022","unstructured":"Boarescu I, et al. Anti-inflammatory and analgesic effects of curcumin nanoparticles associated with diclofenac sodium in experimental acute inflammation. Int J Mol Sci. 2022;23(19):11737.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2084_CR31","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/01932691.2023.2289625","volume":"45","author":"J Akbari","year":"2024","unstructured":"Akbari J, et al. Green preparation, charetrization, in vitro\/in vivo safety assessment and in vivo pain management of nortriptyline HCl loaded in niosome (norosome) manufactured by ecofriendly green method. J Dispers Sci Technol. 2024;45(4):819\u201331.","journal-title":"J Dispers Sci Technol"},{"issue":"9","key":"2084_CR32","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1080\/10717544.2016.1183721","volume":"23","author":"RM Abd-Elal","year":"2016","unstructured":"Abd-Elal RM, et al. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Drug Deliv. 2016;23(9):3374\u201386.","journal-title":"Drug Deliv"},{"key":"2084_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jconrel.2022.10.011","volume":"352","author":"MC Bruno","year":"2022","unstructured":"Bruno MC, et al. Oleic acid-based vesicular nanocarriers for topical delivery of the natural drug thymoquinone: Improvement of anti-inflammatory activity. J Control Release. 2022;352:74\u201386.","journal-title":"J Control Release"},{"key":"2084_CR34","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.biopha.2018.07.084","volume":"106","author":"K Khezri","year":"2018","unstructured":"Khezri K, Saeedi M, Dizaj SM. Application of nanoparticles in percutaneous delivery of active ingredients in cosmetic preparations. Biomed Pharmacother. 2018;106:1499\u2013505.","journal-title":"Biomed Pharmacother"},{"key":"2084_CR35","doi-asserted-by":"crossref","unstructured":"Mansour HM, Rhee Y-S, Wu X. Nanomedicine in pulmonary delivery. Int J Nanomedicine. 2009;299\u2013319.","DOI":"10.2147\/IJN.S4937"},{"issue":"3","key":"2084_CR36","doi-asserted-by":"publisher","first-page":"88","DOI":"10.69857\/joapr.v12i3.536","volume":"12","author":"T Rukari","year":"2024","unstructured":"Rukari T, Pingale PL, Upasani CD. Optimizing novasomes: impact of oleic acid and co-surfactant ratio on posaconazole delivery: In vitro & ex vivo pharmacokinetic study. J Appl Pharm Res. 2024;12(3):88\u201398.","journal-title":"J Appl Pharm Res"},{"issue":"3","key":"2084_CR37","first-page":"103","volume":"5","author":"P Kumar","year":"2018","unstructured":"Kumar P, et al. Oleic acid nanovesicles of minoxidil for enhanced follicular delivery. Medicines (Basel). 2018;5(3):103.","journal-title":"Medicines (Basel)"},{"issue":"1","key":"2084_CR38","first-page":"561","volume":"5","author":"V Mohanraj","year":"2006","unstructured":"Mohanraj V, Chen Y. Nanoparticles-a review. Trop J Pharm Res. 2006;5(1):561\u201373.","journal-title":"Trop J Pharm Res"},{"issue":"2","key":"2084_CR39","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1208\/s12249-016-0528-9","volume":"18","author":"NI Elsherif","year":"2017","unstructured":"Elsherif NI, Shamma RN, Abdelbary G. Terbinafine hydrochloride trans-ungual delivery via nanovesicular systems: in vitro characterization and ex vivo evaluation. AAPS PharmSciTech. 2017;18(2):551\u201362.","journal-title":"AAPS PharmSciTech"},{"key":"2084_CR40","doi-asserted-by":"publisher","unstructured":"Essa EA. Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes. Asian J Pharm. 2010;4(4):227\u2013233. https:\/\/doi.org\/10.4103\/0973-8398.76752.","DOI":"10.4103\/0973-8398.76752"},{"key":"2084_CR41","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.chemphyslip.2018.04.002","volume":"213","author":"K Tall\u00f3","year":"2018","unstructured":"Tall\u00f3 K, et al. Vesicular nanostructures composed of oleic acid and phosphatidylcholine: effect of pH and molar ratio. Chem Phys Lipids. 2018;213:96\u2013101.","journal-title":"Chem Phys Lipids"},{"issue":"11","key":"2084_CR42","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.2042-7158.1996.tb03908.x","volume":"48","author":"K Morimoto","year":"1996","unstructured":"Morimoto K, et al. Enhancing effects of unsaturated fatty acids with various structures on the permeation of indomethacin through rat skin. J Pharm Pharmacol. 1996;48(11):1133\u20137.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2084_CR43","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1194\/jlr.M200356-JLR200","volume":"44","author":"SS Funari","year":"2003","unstructured":"Funari SS, Barcel\u00f3 F, Escrib\u00e1 PV. Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes. J Lipid Res. 2003;44(3):567\u201375.","journal-title":"J Lipid Res"},{"issue":"3","key":"2084_CR44","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1590\/S1984-82502015000300012","volume":"51","author":"MI Khan","year":"2015","unstructured":"Khan MI, et al. Formulation design and characterization of a non-ionic surfactant based vesicular system for the sustained delivery of a new chondroprotective agent. Braz J Pharm Sci. 2015;51(3):607\u201315.","journal-title":"Braz J Pharm Sci"},{"issue":"10","key":"2084_CR45","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1211\/0022357991776813","volume":"51","author":"GME Maghraby","year":"1999","unstructured":"Maghraby GME, Williams AC, Barry BW. Skin delivery of oestradiol from deformable and traditiona liposomes: mechanistic studies. J Pharm Pharmacol. 1999;51(10):1123\u201334.","journal-title":"J Pharm Pharmacol"},{"key":"2084_CR46","doi-asserted-by":"crossref","unstructured":"Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev. 2012;64(1):175\u2013193.","DOI":"10.1016\/j.addr.2012.09.018"},{"key":"2084_CR47","unstructured":"Pando Rodr\u00edguez D. Formulation and preparation of niosomes containing bioactive compounds. PhD Thesis, Universidad de Oviedo (university, Oviedo, Spain); 2014."},{"issue":"1","key":"2084_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5530\/jyp.20251440","volume":"17","author":"MA Mustafa","year":"2025","unstructured":"Mustafa MA, et al. Novasomes: a versatile drug delivery system for enhanced therapeutic efficacy. J Young Pharm. 2025;17(1):36\u201345.","journal-title":"J Young Pharm"},{"issue":"44","key":"2084_CR49","doi-asserted-by":"publisher","first-page":"21125","DOI":"10.1021\/acsanm.5c03463","volume":"8","author":"KP Alcantara","year":"2025","unstructured":"Alcantara KP, et al. Review of chitosan-coated nanoscale liposomes for enhanced drug delivery. ACS Appl Nano Mater. 2025;8(44):21125\u201347.","journal-title":"ACS Appl Nano Mater"},{"issue":"2","key":"2084_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1021\/bi00053a016","volume":"32","author":"TP McMullen","year":"1993","unstructured":"McMullen TP, Lewis RN, McElhaney RN. Differential scanning calorimetric study of the effect of cholesterol on the thermotropic phase behavior of a homologous series of linear saturated phosphatidylcholines. Biochemistry. 1993;32(2):516\u201322.","journal-title":"Biochemistry"},{"issue":"6","key":"2084_CR51","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/1061186X.2025.2456929","volume":"33","author":"AB Darwish","year":"2025","unstructured":"Darwish AB, Salama A, Al-Samadi IEI. Formulation, optimisation, and evaluation of Lornoxicam-loaded Novasomes for targeted ulcerative colitis therapy: in vitro and in vivo investigations. J Drug Target. 2025;33(6):975\u201388.","journal-title":"J Drug Target"},{"key":"2084_CR52","unstructured":"Shamma RNE. Development of novel novasome-based formulations for enhanced transdermal delivery of anti-inflammatory drugs. Int J Pharm.\u00a02021;606:120\u2013131."},{"key":"2084_CR53","doi-asserted-by":"crossref","unstructured":"Aji W. Preliminary study plate capacitor as a Plethysmometer sensor. In: IOP Conference Series: Materials Science and Engineering. 2018. IOP Publishing.","DOI":"10.1088\/1757-899X\/403\/1\/012036"},{"issue":"6","key":"2084_CR54","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1039\/D2NA00530A","volume":"5","author":"L Liu","year":"2023","unstructured":"Liu L, et al. Functional nano-systems for transdermal drug delivery and skin therapy. Nanoscale Adv. 2023;5(6):1527\u201358.","journal-title":"Nanoscale Adv"},{"key":"2084_CR55","doi-asserted-by":"crossref","unstructured":"Kassem AA, Abd El-Alim SH. Vesicular Nanocarriers: a potential platform for dermal and transdermal drug delivery. In: Nanopharmaceuticals: Principles and Applications. 2020;2:155\u2013209.","DOI":"10.1007\/978-3-030-44921-6_5"},{"issue":"3","key":"2084_CR56","first-page":"611","volume":"10","author":"V Hajhashemi","year":"2011","unstructured":"Hajhashemi V, et al. Effect of fluvoxamine on carrageenan-induced paw edema in rats evaluation of the action sites. Iranian Journal of Pharmaceutical Research: IJPR. 2011;10(3):611.","journal-title":"Iranian Journal of Pharmaceutical Research: IJPR"},{"key":"2084_CR57","doi-asserted-by":"publisher","first-page":"110758","DOI":"10.1016\/j.colsurfb.2019.110758","volume":"187","author":"ML de Lourdes P\u00e9rez-Gonz\u00e1lez","year":"2020","unstructured":"de Lourdes P\u00e9rez-Gonz\u00e1lez ML, et al. Nanostructured oleic acid\/polysorbate 80 emulsions with diminished toxicity in NL-20 cell line: Insights of potential drug carriers. Colloids Surf, B. 2020;187:110758.","journal-title":"Colloids Surf, B"},{"key":"2084_CR58","doi-asserted-by":"crossref","unstructured":"Zhang XZY, Yang J, et al. Surfactant\u2011enabled nanocarriers in drug delivery: mechanisms and applications Pharmaceutics. 2025;17(6):779.","DOI":"10.3390\/pharmaceutics17060779"},{"key":"2084_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.jconrel.2022.10.011","volume":"352","author":"SC Ghasemi","year":"2022","unstructured":"Ghasemi SC, Biray Avci \u00c7, Mancuso A, Barone A, Tarsitano M, Cosco D, Paolino D, Fresta M. Oleic acid-based vesicular nanocarriers for topical delivery of the natural drug thymoquinone: improvement of anti-inflammatory activity. J Control Release. 2022;352:74\u201386.","journal-title":"J Control Release"},{"issue":"19","key":"2084_CR60","doi-asserted-by":"publisher","first-page":"16620","DOI":"10.1021\/acsomega.2c07254","volume":"8","author":"AA Abd-Elghany","year":"2023","unstructured":"Abd-Elghany AA, Mohamad EA. Chitosan-coated niosomes loaded with ellagic acid present antiaging activity in a skin cell line. ACS Omega. 2023;8(19):16620\u20139.","journal-title":"ACS Omega"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02084-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02084-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T14:04:10Z","timestamp":1774361050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02084-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":60,"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02084-y","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,24]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}